Title |
Growth and Nutrition in Pediatric Chronic Kidney Disease
|
---|---|
Published in |
Frontiers in Pediatrics, August 2018
|
DOI | 10.3389/fped.2018.00205 |
Pubmed ID | |
Authors |
Douglas M. Silverstein |
Abstract |
Children with chronic kidney disease (CKD) feature significant challenges to the maintenance of adequate nutrition and linear growth. Moreover, the impaired nutritional state contributes directly to poor growth. Therefore, it is necessary to consider nutritional status in the assessment of etiology and treatment of sub-optimal linear growth. The major causes of poor linear growth including dysregulation of the growth hormone/insulin-like growth factor-I (IGF-I) axis, nutritional deficiency, metabolic acidosis, anemia, renal osteodystrophy/bone mineral disease, and inflammation. This review summarizes the causes and assessment tools of growth and nutrition while providing a summary of state of the art therapies for these co-morbidities of pediatric CKD. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 10% |
Canada | 1 | 10% |
Mexico | 1 | 10% |
United Kingdom | 1 | 10% |
Switzerland | 1 | 10% |
Unknown | 5 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 70% |
Practitioners (doctors, other healthcare professionals) | 2 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 154 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 24 | 16% |
Student > Master | 17 | 11% |
Other | 17 | 11% |
Student > Postgraduate | 13 | 8% |
Student > Ph. D. Student | 7 | 5% |
Other | 16 | 10% |
Unknown | 60 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 46 | 30% |
Nursing and Health Professions | 23 | 15% |
Biochemistry, Genetics and Molecular Biology | 6 | 4% |
Immunology and Microbiology | 5 | 3% |
Computer Science | 2 | 1% |
Other | 13 | 8% |
Unknown | 59 | 38% |